Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2005
12/22/2005CA2568306A1 Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody
12/22/2005CA2568304A1 Furanopyrimidine compounds effective as potassium channel inhibitors
12/22/2005CA2568301A1 3-phenyltetrahydrocinnolin-5-ol derivatives and medicinal use thereof of
12/22/2005CA2567847A1 Novel tetracyclic tetrahydrofuran derivatives
12/22/2005CA2567845A1 4-phenyl-pyrimidine-2-carbonitrile derivatives
12/22/2005CA2567835A1 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/22/2005CA2567821A1 Quinazolinone derivatives useful as vanilloid antagonists
12/22/2005CA2567513A1 Histamine h3 receptor agents, preparation and therapeutic uses
12/22/2005CA2567477A1 Combination of radio waves and pharmacologically active substances
12/22/2005CA2567342A1 Aza-bicyclo[3.1.0]hex-1-yl derivatives active as nk1 antagonists
12/22/2005CA2567311A1 Method of decreasing sebum production and pore size
12/22/2005CA2567268A1 Thienopyridinone compounds and methods of treatment
12/22/2005CA2567205A1 Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition therefor in form of a kit
12/22/2005CA2567063A1 Dosage form containing the active ingredient cholylsarcosine
12/22/2005CA2567043A1 Biosynthetic gene cluster for the production of a complex polyketide
12/22/2005CA2566951A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
12/22/2005CA2566772A1 (diaryl-methyl)-malononitriles and their use as estrogen receptor ligands
12/22/2005CA2566771A1 Sugar coatings and methods therefor
12/22/2005CA2566525A1 Thiophene derivatives, their manufacture and use as pharmaceutical agents
12/22/2005CA2566515A1 Thiophene hydroxamic acid derivatives and their use as hdac inhibitors
12/22/2005CA2566512A1 Hydroxamates, their manufacture and use as pharmaceutical agents
12/22/2005CA2565698A1 Benzimidazoles, method for producing them and the use thereof as drugs
12/22/2005CA2565262A1 Nutritional formulations
12/22/2005CA2565102A1 Novel use of peptide compounds for treating amyotrophic lateral sclerosis
12/22/2005CA2565101A1 Novel use of peptide compounds for treating pain in trigeminal neuralgia
12/22/2005CA2564499A1 Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity
12/22/2005CA2561831A1 Polycyclic pyrazines as potassium ion channel modulators
12/22/2005CA2557942A1 2h or 3h-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof
12/22/2005CA2529445A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/22/2005CA2510813A1 Injectable pharmaceutical compositions comprising sodium diclofenac and .beta.-cyclodextrin
12/21/2005EP1607744A2 Treatment of diseases involving cyst formation with combinations comprising a PTBR agonist
12/21/2005EP1607402A1 Method for the diagnosis of tumour
12/21/2005EP1607401A1 Novel aryl fructose-1,6-Bisphosphatase inhibitors
12/21/2005EP1607399A2 BIS-(N,N'-BIS-(2-Haloethyl)Amino) Phosphoramidates as antitumor agents
12/21/2005EP1607396A1 Bicyclic inhibitors of glycogen synthase kinase 3
12/21/2005EP1607394A1 Water-soluble thalidomine derivatives
12/21/2005EP1607387A2 3,4,4-trisubstituted piperidine derivatives and their use as opioid antagonists
12/21/2005EP1607386A1 Lipid metabolism improving agent
12/21/2005EP1607385A1 Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
12/21/2005EP1607384A1 Novel functional peptide nucleic acid and process for producing the same
12/21/2005EP1607103A1 Concomitant drug as therapeutic agent for inflammatory bowel disease
12/21/2005EP1607102A1 Preventive for adhesion following abdominal surgery
12/21/2005EP1607099A1 Use of hyperforin derivatives as an antidepressant agent
12/21/2005EP1607097A2 Stabilized compositions containing an oxygen-labile agent
12/21/2005EP1607095A1 Antipruritic composition for external use on skin
12/21/2005EP1607093A1 Improved delivery of multiple doses of medications
12/21/2005EP1607092A1 Release control compositions
12/21/2005EP1607091A1 Antihepatitis c virus agent and anti-hiv agent
12/21/2005EP1607090A1 Asimadoline for the treatment of irritable bowel syndrome
12/21/2005EP1607089A1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
12/21/2005EP1607088A1 Controlled release composition
12/21/2005EP1607087A1 Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis
12/21/2005EP1607005A1 The effect of a buffering agent on acidogenesis of plaque
12/21/2005EP1606311A1 Interferon-alpha induced gene
12/21/2005EP1606307A1 ESTRIENO(3,2-b)/(3,4-c)PYRROLE DERIVATIVES USEFUL AS MODULATORS OF THE ESTROGEN RECEPTORS
12/21/2005EP1606302A2 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors
12/21/2005EP1606301A2 Aptamer therapeutics useful in ocular pharmacotherapy
12/21/2005EP1606299A1 Degradation products of azithromycin, and methods for their identification
12/21/2005EP1606297A2 High viscosity xanthan polymer preparations
12/21/2005EP1606293A1 Cephalosporin in crystalline form
12/21/2005EP1606292A2 Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications
12/21/2005EP1606290A1 Weak base salts
12/21/2005EP1606286A2 Benodiazepine spirohydantoin cgrp receptor antagonists
12/21/2005EP1606285A1 Novel ido inhibitors and methods of use
12/21/2005EP1606284A1 Compositions useful as protein kinase inhibitors
12/21/2005EP1606283A2 P38 inhibitors and methods of use thereof
12/21/2005EP1606281A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/21/2005EP1606279A1 Polymorphs of s-omeprazole
12/21/2005EP1606278A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators
12/21/2005EP1606277A1 Imidazol-4-yl-ethynyl-pyridine derivatives
12/21/2005EP1606269A1 Biaryl substituted triazoles as sodium channel blockers
12/21/2005EP1606267A1 Pyrazine compounds as transforming growth factor (tgf) inhibitors
12/21/2005EP1606265A1 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
12/21/2005EP1606263A1 Ring-substituted 8-aminoquinoline derivatives as antimalarial agents
12/21/2005EP1606262A1 Novel crystalline forms of aripiprazole
12/21/2005EP1606260A1 Oxamide derivatives useful as raf-kinase inhibitors
12/21/2005EP1606256A2 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses
12/21/2005EP1606255A2 Cyclic derivatives as modulators of chemokine receptor activity
12/21/2005EP1606253A1 Production of 5-methyl-n-aryl-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone by reductive amination of leuvlinic acid esters with nitro compounds
12/21/2005EP1606248A2 Sulfonic acids, their derivatives and pharmaceutical compositions containing them
12/21/2005EP1606247A1 Substituted aniline derivatives
12/21/2005EP1606246A1 Method for producing 2-cyan-3-hydroxy-n-(phenyl)but-2-ene amides
12/21/2005EP1606244A2 Cycloalkylamides and their therapeutic use as antiepileptic and anticonvulsant
12/21/2005EP1606233A2 Nucleotide lipid ester derivatives
12/21/2005EP1606231A1 Process for preparation of clopidogrel, its salts and pharmaceutical compositions
12/21/2005EP1606021A1 Manganese based organometallic complexes, pharmaceutical compositions and dietetic products
12/21/2005EP1606020A2 5ht2c receptor antagonists in the treatment of schizophrenia
12/21/2005EP1606019A1 Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders
12/21/2005EP1605976A1 PHENYLCARBOXYL ACID AMIDES AND IK r CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA
12/21/2005EP1605966A1 Use of chemokine receptor agonists for stem cell transplantation
12/21/2005EP1605958A1 Compositions of natural products and use thereof
12/21/2005EP1605956A1 Administration of capsaicinoids
12/21/2005EP1605955A2 Anti-inflammatory composition based on strontium compounds
12/21/2005EP1605954A1 A food-supplement composition suitable for promoting iron absorption
12/21/2005EP1605952A1 Use of 5-substituted nucleosides for reinforcing the apoptotic effect of cytostatic drugs
12/21/2005EP1605951A1 Combined therapy comprising nemorubicin and a cyclooxygenase-2-inhibitor
12/21/2005EP1605950A2 Novel chemical entities and methods for their use in treatment of metabolic disorders
12/21/2005EP1605949A2 Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives
12/21/2005EP1605948A1 Prostaglandin compositions for the treatment of erectile dysfunction
12/21/2005EP1605947A1 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
1 ... 4427 4428 4429 4430 4431 4432 4433 4434 4435 4436 4437 4438 4439 4440 4441 4442 4443 4444 4445 4446 4447 ... 7860